Q4 2025 Modern Oral Net Sales increased 266% to $41.3 million, accounting for 34% of total company net sales, up from 12% in Q4 2024. Total Consolidated Net Sales increased 29.2% to $121.0 million in Q4 2025 and 28.4% to $463.1 million for the full year 2025. Adjusted EBITDA increased 14.4% to $30.0 million in Q4 2025 and 14.4% to $119.5 million for the full year 2025. Net Income increased 239.8% to $8.2 million in Q4 2025 and 46.1% to $58.2 million for the full year 2025. Stoker's segment Net Sales increased 69.5% in Q4 2025 and 69.1% for FY 2025, primarily due to triple-digit growth in Modern Oral sales. Zig-Zag segment Net Sales decreased 12.8% in Q4 2025 and 7.2% for FY 2025, attributed to the planned wind-down of the Clipper business and resource allocation to white pouch products. The company ended Q4 2025 with $222.8 million in cash and $77.2 million in net debt, with total liquidity of $290.1 million. Management provided FY 2026 guidance for Modern Oral Gross Revenue of $220-$240 million and Net Revenue of $180-$190 million.